Publications of R. Rupprecht
All genres
Journal Article (107)
61.
Journal Article
306, pp. 81 - 84 (2001)
The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N 1 E-115 cell systems in a non-competitive manner. Neuroscience Letters 62.
Journal Article
46, pp. 461 - 477 (2001)
Neuroactive steroids in neuropsychopharmacology. International Review of Neurobiology 63.
Journal Article
86, pp. 1610 - 1615 (2001)
Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized double blind trial. Journal of Clinical Endocrinology & Metabolism 64.
Journal Article
1, pp. 137 - 143 (2000)
Pharmacological characterisation of cortical gamma-aminobutyric acid type A (GABA-A) receptors in two wistar rat lines selectively bred for high- and low-anxiety-treated behavior. World Journal of Biological Psychiatry 65.
Journal Article
34, pp. 265 - 276 (2000)
Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. Journal of Psychiatric Research 66.
Journal Article
22, pp. 251 - 256 (2000)
Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Neuropsychopharmacology 67.
Journal Article
34, pp. 183 - 186 (2000)
Fluoxetine decreases concentrations of 3a,5a- tetrahydrodeoxycorticosterone (THDOC) in major depression. Journal of Psychiatric Research 68.
Journal Article
141, pp. 213 - 219 (1999)
The GABAA receptor antagonist picrotoxin attenuates most sleep changes induced by progesterone. Psychopharmacology 69.
Journal Article
70, pp. 36 - 44 (1999)
Po gene expression is modulated by androgens in the sciatic nerve of adult male rats. Molecular Brain Research 70.
Journal Article
22, pp. 410 - 416 (1999)
Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends in Neurosciences 71.
Journal Article
64, pp. 83 - 91 (1999)
Neuropsychopharmacological effects of neuroactive steroids. Steroids 72.
Journal Article
143, pp. 29 - 38 (1999)
Assessment of neuroleptic-like properties of progesterone. Psychopharmacology 73.
Journal Article
70, pp. 265 - 268 (1999)
Koinzidenz von schizophrener Psychose und Panikstörung mit Agoraphobie. Nervenarzt 74.
Journal Article
45, pp. 274 - 277 (1999)
Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biological Psychiatry 75.
Journal Article
246, pp. 292 - 298 (1999)
Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. Journal of Neurology 76.
Journal Article
53, pp. 772 - 777 (1999)
Dysregulation of the hypothalamic-pituitary-adrenal axis is related to the clinical course of multiple sclerosis. Neurology 77.
Journal Article
141, pp. 213 - 219 (1998)
The GABAA receptor antagonist picrotoxin attenuates most of the sleep changes induced by progesterone. Psychopharmacology 78.
Journal Article
53, pp. 202 - 212 (1998)
Molecular cloning, functional expression and pharmacological characterization of 5-HT3 receptor cDNA and its splice variants from guinea pig. Molecular Pharmacology 79.
Journal Article
155, pp. 910 - 913 (1998)
Effects of antidepressant treatment on neuroactive steroids in major depression. American Journal of Psychiatry 80.
Journal Article
44, pp. 912 - 914 (1998)
Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers. Biological Psychiatry